Developing Next-Generation
Immunotherapies

AdvantiGen is expanding the landscape of Immuno-Oncology (IO) by unveiling sialic-acid-binding immunoglobulin-like lectin 5 (Siglec-5) as a novel target on activated T-cells for cancer immunotherapy.

To fulfill the promise of this new Siglec-based IO axis, we capitalize on our expertise in monoclonal antibodies (mAbs) and NIRID™ (Near InfraRed Identification and Detection), to develop state-of-the-art therapeutics and complementary biomarkers. These advancements are instrumental in ensuring robust pre-clinical and clinical patient selection and stratification. 

Siglec-5 engages with various cancer cell types, indicating its clinical significance in both solid tumors—such as those found in the skin, kidney, breast, colorectal, lung, and liver—and blood cancers, including T cell lymphoma, acute monocytic leukemia, and B cell lymphoma.

Team

Executives

Pascal Longchamp, Ph.D. MBA 
Chief Executive Officer 
Serial entrepreneur with 20+ years of experience in biotech/pharma

Howard Teeter 
Chief Financial Officer
40+ years experience in pharma, CDMO, founder, CEO and successful trade sales exit 

Heather Kirkpatrick 
Chief Business Officer 
Multi-functional leader with 20+ years of experience in biotech/pharma

Founders

Andrew Ulijasz, Ph.D.  
Chief Scientific Officer
Associate Professor of Microbiology and Immunology with 25+ years experience in the field

Mark Jackson
Chief Operation Officer
20+ years in Biotech managing antibody development

Advisors
Scientific, Pre-Clinical, Clinical & Biomarker

  • T Cell / ICI Immunologist
    Microbiology and Immunology Department, Loyola University Chicago

  • Near Infrared Inventor, Biomarkers
    Professor & Chair of Bacteriology Department, UW-Madison

  • Immunologist
    Professor, Department of Medicine/ Department of Microbiology and Immunology, UW-Madison

  • Clinical Oncology Expert
    Professor Froedtert & Medical College of Wisconsin in Hematology and Oncology

  • Early Clinical Immuno-oncology Development Expert
    CEO, Jmi ONConsulting, 20+ years experience in pharma (Sanofi, J&J)

Meet Us At…

Contact Us

 

Advantigen Biosciences
510 Charmany Dr, Suite 270
Madison, WI. 53719
USA